Cannabis consumers are a diverse group, as clearly demonstrated by BDSA’s consumer research. At the highest level, BDSA divides respondents into:
When Colorado first launched adult-use (recreational) sales in 2014, the existing medical market opened up to a wave of new consumers, including those from the sizable illicit market as well as new consumers who previously had little or no experience with cannabis.
The popularity of CBD products has exploded in the U.S. in recent years, with sales in the U.S. cannabis dispensary channel alone rising from $8.4 million in May 2016 to $56.9 million in May 2020. And hemp-derived CBD products, containing less than 0.3% THC, are increasingly available via general retail channels, though CBD ingestibles are still officially off limits for sale in general retail channels in the U.S. and most other jurisdictions.
The legal cannabis market has exploded in recent years, with sales in the U.S. reaching an estimated $12.4 billion in 2019, forecast to rise to $31 billion by 2024. The market for cannabidiol (CBD) has also grown rapidly, with U.S. sales totaling $2.6 billion in 2019, on track to reach $18 billion by 2024. While THC and CBD are the most widely known and marketed compounds found in Cannabis sativa, a few of the other 113 currently identified cannabinoids show potential for therapeutic and recreational applications and have attracted the attention of both researchers and those in the industry.
- Independence Day and cannabis go hand-in-hand: “daytime fun” and well as “celebrating special events” are top occasions for cannabis consumption.
- Cannabis sales spiked in the days surrounding the July 4th holiday in 2019, increasing 31% between July 1-3, and 21% between July 4-6.
- Although inhalable products – flower and concentrates – comprised the majority of sales in the days surrounding July 4th 2019, ingestible products experienced a boost in sales before and after the holiday, increasing 27% during July 1-6 - with candy experiencing the sharpest increase of 50% during the first week in July
- Independence Day offers day-to-night festivities as well as opportunities for consumption. Inhalables are the top product choice for daytime and evening consumption, perfect for transitioning from backyard BBQs to late night fireworks!
- July 4th celebrations involve pairings of friends, food and festivities: 30% of consumers typically pair alcohol and cannabis in group settings.
Interested in gaining more valuable insights from BDSA? Contact us today!
BOULDER, Colo. — May 5, 2020 —BDSA (formerly BDS Analytics), the leader in comprehensive, accurate and actionable cannabis market intelligence and consumer research, announced today that Illinois retail cannabis sales exceeded $188 million in the first quarter of 2020, reflecting adult-use sales of $109.96 million and medical sales of $78.2 million. This year’s sales are projected to exceed $693 million, an increase of 176%, based on top-line sales projections modeled from point-of-sale transaction records.
The COVID-19 public health crisis reset societies around the globe in just a few short months. With more than 150,000 deaths as of this writing, per the Johns Hopkins coronavirus resource center, no aspect of our lives remains untouched. The Easter and Passover holidays were forced online and over 22 million Americans have lost their jobs in the last few weeks. Global economies are in shambles and economists are virtually guaranteeing a recession (i.e., two consecutive quarters of negative GDP growth).
As more U.S. states move towards legalization, cannabis consumers are taking advantage of the unique opportunity to address medical needs through the available products at their local dispensaries. Though medical cannabis is generally not covered by most U.S. insurance plans, trends indicate increased use of cannabis as an alternative to more traditional forms of medication. Here are BDS Analytics' Top 5 Insights into the impact of legal cannabis sales on the over-the-counter (OTC) and prescription drug channels: